Effectiveness and cost-effectiveness of a health systems intervention for latent tuberculosis infection management (ACT4): a cluster-randomised trial

• Autori principali: Olivia Oxlade, PhD (Autore), Andrea Benedetti, PhD (Autore), Mênonli Adjobimey, MD (Autore), Hannah Alsdurf, PhD (Autore), Severin Anagonou, ProfPhD (Autore), Victoria J Cook, MD (Autore), Dina Fisher, MD (Autore), Greg J Fox, PhD (Autore), Federica Fregonese, MD (Autore), Panji Hadisoemarto, MD (Autore), Philip C Hill, ProfMD (Autore), James Johnston, MD (Autore), Faiz Ahmad Khan, MD (Autore), Richard Long, MD (Autore), Nhung V Nguyen, MD (Autore), Thu Anh Nguyen, PhD (Autore), Joseph Obeng, MD (Autore), Rovina Ruslami, ProfPhD (Autore), Kevin Schwartzman, ProfMD (Autore), Anete Trajman, ProfMD (Autore), Chantal Valiquette (Autore), Dick Menzies, ProfMD (Autore)
• Natura: Libro
• Pubblicazione: Elsevier, 2021-05-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Summary: Background: Reaching the UN General Assembly High-Level Meeting on Tuberculosis target of providing tuberculosis preventive treatment to at least 30 million people by 2022, including 4 million children under the age of 5 years and 20 million other household contacts, will require major effo...